Medable

07/21/2025

Launching oncology trials is difficult. Medable Studio makes it easier.

From 90% faster eCOA builds to streamlined localization support in over 70 countries, we're helping teams spend less time on tech and more time on science.

🎥 Watch the quick demo below!
________

07/18/2025

Give your clinical sites the kind of experience they actually want — intuitive, reliable, and built to support how they work. 🤝

Medable for Sites offers full study visibility with fewer clicks and less friction. Built-in guardrails help ensure better data quality, while simplified workflows ease the operational load so sites can focus on what matters most.

When your sites spend less time troubleshooting and more time with patients, everyone wins.

Send this account a DM to learn more! 📨
________

07/15/2025

“More than 9 times out of 10, we get the user the information they need on their first call with us.”

Medable’s SVP of Professional Services, Carl Franzetti, discusses our approach to world-class help desk operations and support for sponsors, sites, and patients.

Watch below!
________

07/14/2025

Agentic AI is here, and it's reshaping what's possible in clinical research. 💥

We're moving from AI that supports decisions to AI that can make and act on them.

To maximize its potential, it needs quality data, strong infrastructure, smart integration, and the right balance between automation and indispensable human oversight.

This is where innovation meets responsibility. 🤝

👉 Learn more here: https://www.medable.com/knowledge-center/guides-back-to-basics-agentic-ai-and-how-its-impacting-clinical-trial-research
________

07/08/2025

A top-3 CRO and a top-10 pharmaceutical company partnered with Medable to help accelerate the speed, scale, and standardization of their eCOA delivery.

Long configuration timelines, inconsistent designs across studies, and siloed processes had hampered both organizations.

By centralizing the sponsor’s preferred instruments and configurations into a reusable digital library, Medable enabled the CRO to rapidly accelerate its portfolio development and initiate new studies without starting them “from scratch.”

Find out more here: https://www.medable.com/knowledge-center/long-form-case-study-accelerating-cro-study-deployment-at-scale?utm_source=linkedin&utm_medium=organic&utm_campaign=&utm_content=
________

07/07/2025

In this episode of The Hem Onc Pulse podcast, Dr. Michelle Longmire, CEO and co-founder of Medable, discusses one of the most pressing challenges in oncology today: drug accessibility.

Despite the rapid pace of innovation in cancer therapeutics, many patients still face significant barriers to accessing life-saving treatments.

Dr. Longmire offers insights into how decentralized clinical trials, digital platforms, and patient-centered design can help close the gap, particularly for underserved populations.

👉 Listen here: https://www.bloodcancerstoday.com/podcast/navigating-drug-accessibility-in-cancer-care
_______

Dr. Rahul Banerjee and Dr. Michelle Longmire discuss how tech and trial innovation can improve cancer drug accessibility.

07/04/2025

Happy 4th of July from ! 🇺🇸

07/02/2025

The promise of cell and gene therapies (CGTs) remains enormous, but the operational realities of long-term follow-up (LTFU), including high costs, patient attrition, and site burdens, pose serious threats to continued progress.

Digital solutions offer a powerful way forward. Through telemedicine, remote data capture, and patient engagement technologies, technological innovations are redefining how LTFU can be conducted, ensuring that CGT advances remain both scientifically rigorous and economically viable for years to come.

Learn more from our Chief Medical Officer, Dr. Pamela Tenaerts, here: https://informaconnect.com/digital-solutions-hold-the-key-to-managing-long-term-follow-up-for-gene-and-cell-therapies/
_________

“CGTs are already considered a mainstream treatment option for lymphomas and all multiple myelomas, but there are still true barriers because it is logistically complex, expensive, and only administered at limited locations,” explained Kaitlin Morrison, MD, Assistant Professor of Medicine and Ex...

07/01/2025

Medable Caregiver keeps study participants informed, engaged, and confident—while ensuring sponsors receive consistent, high-quality data from start to finish.

Watch the express demo of our solution to find out we support multiple caregivers, multiple devices, and multiple realities within a single application: https://www.medable.com/knowledge-center/webinar-medable-caregiver-demo
________

06/30/2025

As the eCOA landscape continues to evolve, it’s crucial that industry stakeholders separate lingering misconceptions from evidence-based practices.

This blog breaks down the five biggest myths around eCOA deployment to help clinical operations, procurement, and data management teams make smarter, faster decisions.

👉 If you're rethinking how to streamline your trials, start here: https://www.medable.com/knowledge-center/blog-the-top-5-myths-about-ecoa-in-2025
________

06/26/2025

Our CRO Partner Program delivers business-winning tools to those who don't have time to waste.

Generate study-specific quotes in 30 seconds with our self-serve pricing calculator.

Find out how to unlock our partner incentives here: https://www.medable.com/solutions/cro?utm_source=linkedin&utm_medium=organic&utm_campaign=&utm_content=
________

06/25/2025

📢 What does it really take to scale digital and decentralized trials?

Join Alison Holland, Medable’s Chief Customer Officer, tomorrow at the 5th Annual Clinical Trial Innovation Summit as she shares a recent case study on what works (and what doesn’t) when bringing DCTs to life.

Real evidence, real outcomes, and practical insights. You'll want to be in the room for this one!

📍Live from Roche HQ, Basel
🔗 Register now: https://digitaltrialsx.panagorapharma.com
________